Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
DOI: 10.1007/s00394-025-03618-9, Liu, Y., Cotillard, A., Vatier, C., et al
Precision Testing Profiles 29 mold-related toxins to clarify patterns of exposure that may be adding to symptom load
Many users find branded GLP-1s are not affordable and turn to lower cost sources, such as getting semaglutide made up by a compounding pharmacy (often requesting additions to the formula such as vitamin B12) a practice that is not recommended by the US FDA.13 This may decrease as the first generic versions of GLP-1 drugs become available, which started to get FDA approval in late 2024
When insulin glargine was added to the list in 2022, the NPPA introduced a price cap